• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

佩吉特病：帕米膦酸二钠治疗的眼部并发症

Paget's disease: ocular complications of disodium pamidronate treatment.

作者信息

O'Donnell N P, Rao G P, Aguis-Fernandez A

机构信息

St. Paul's Eye Unit, Royal Liverpool University Hospital.

出版信息

Br J Clin Pract. 1995 Sep-Oct;49(5):272-3.

PMID:7492469
Abstract

Three cases of uveitis associated with disodium pamidronate have been notified to the Committee for Safety of Medicines. Two new cases of bilateral anterior uveitis and episcleritis after administration of intravenous disodium pamidronate are described.

摘要

已有三例与帕米膦酸二钠相关的葡萄膜炎病例报告给药品安全委员会。本文描述了两例静脉注射帕米膦酸二钠后发生双侧前葡萄膜炎和巩膜炎的新病例。

相似文献

1
Paget's disease: ocular complications of disodium pamidronate treatment.佩吉特病：帕米膦酸二钠治疗的眼部并发症
Br J Clin Pract. 1995 Sep-Oct;49(5):272-3.
2
Pamidronate disodium and possible ocular adverse drug reactions.帕米膦酸二钠与可能的眼部药物不良反应。
Am J Ophthalmol. 1994 Aug 15;118(2):220-4. doi: 10.1016/s0002-9394(14)72902-2.
3
Uveitis associated with pamidronate.与帕米膦酸盐相关的葡萄膜炎。
Aust N Z J Med. 1994 Jun;24(3):320. doi: 10.1111/j.1445-5994.1994.tb02186.x.
4
A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.一项比较口服阿仑膦酸盐和静脉注射帕米膦酸盐治疗骨Paget病的随机临床试验。
Bone. 2004 Apr;34(4):747-54. doi: 10.1016/j.bone.2003.12.011.
5
A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.骨佩吉特病综述：聚焦5毫克唑来膦酸的疗效与安全性
Curr Med Res Opin. 2008 Mar;24(3):695-705. doi: 10.1185/030079908X260899. Epub 2008 Jan 25.
6
Perspectives: a practical guide to the use of pamidronate in the treatment of Paget's disease.
J Bone Miner Res. 1994 Mar;9(3):303-4. doi: 10.1002/jbmr.5650090302.
7
Pamidronate and uveitis.帕米膦酸盐与葡萄膜炎
Br J Rheumatol. 1995 May;34(5):479. doi: 10.1093/rheumatology/34.5.479.
8
Pamidronate for Paget's disease of the bone.
Br J Hosp Med. 1995;53(3):66-8.
9
Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate disodium.静脉注射帕米膦酸二钠治疗后佩吉特病中阑尾骨丢失的预防
Bone. 1999 Feb;24(2):139-44. doi: 10.1016/s8756-3282(98)00163-x.
10
Treatment of Paget's disease of bone with intravenous pamidronate: comparison of 2 different modes of treatment.
J Rheumatol. 1997 Nov;24(11):2266-7.

引用本文的文献

1
Tolerability of intravenous pamidronate for the treatment of osteoporosis and other metabolic osteopathies: A retrospective analysis.静脉注射帕米膦酸治疗骨质疏松症和其他代谢性骨病的耐受性：一项回顾性分析。
Curr Ther Res Clin Exp. 2007 Jan;68(1):1-22. doi: 10.1016/j.curtheres.2007.03.002.
2
Drug-induced uveitis.药物性葡萄膜炎。
J Ophthalmic Inflamm Infect. 2013 Mar 25;3(1):43. doi: 10.1186/1869-5760-3-43.
3
Safety of long-term bisphosphonate therapy for the management of osteoporosis.长期双膦酸盐治疗骨质疏松症的安全性。
Drugs. 2011 Apr 16;71(6):791-814. doi: 10.2165/11585470-000000000-00000.
4
Acute uveitis following zoledronic acid infusion.唑来膦酸输注后急性葡萄膜炎
Oman J Ophthalmol. 2009 May;2(2):102-3. doi: 10.4103/0974-620X.53046.
5
Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in England.接受利塞膦酸盐治疗患者的眼科事件：通过英国一项处方事件监测研究随访获得的信息总结
Drug Saf. 2006;29(2):151-60. doi: 10.2165/00002018-200629020-00005.
6
Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England.对英格兰基层医疗中13164例开具利塞膦酸盐处方患者的处方事件监测研究。
Osteoporos Int. 2005 Dec;16(12):1989-98. doi: 10.1007/s00198-005-1986-1. Epub 2005 Aug 31.
7
Drug-induced uveitis. Incidence, prevention and treatment.药物性葡萄膜炎。发病率、预防与治疗。
Drug Saf. 1997 Sep;17(3):197-207. doi: 10.2165/00002018-199717030-00005.